NYT director adds 54 dividend-equivalent RSUs; total now 17,973
The New York Times Company (NYT) reported an insider transaction on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The New York Times Company (NYT) reported an insider transaction on a Form 4. Director Manuel Bronstein recorded the acquisition of 54 shares of Class A Common Stock on 10/23/2025 at a price of $0, reflecting Dividend Equivalent RSUs tied to prior RSU awards under the 2020 Incentive Compensation Plan.
Following the transaction, Bronstein’s directly held balance is 17,973 shares. The filing notes that dividend-equivalent RSUs granted on already vested RSUs are fully vested at grant, while those tied to unvested RSUs will vest on the date the related RSUs vest, which is the date of the Company’s first annual meeting following the initial grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 54 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock Units ("RSUs") acquired in respect of previously reported RSUs awarded under The New York Times Company 2020 Incentive Compensation Plan in connection with, and with a value equal to, cash dividends paid on The New York Times Company's Class A Common Stock ("Dividend Equivalent RSUs"). Dividend Equivalent RSUs granted in respect of vested RSUs are fully vested at grant. Dividend Equivalent RSUs granted in respect of unvested RSUs will vest on the date that such unvested RSUs vest, which is the date of the Company's first annual meeting following the initial grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.